Yasmeen Rahimi
Stock Analyst at Piper Sandler
(3.82)
# 671
Out of 4,876 analysts
83
Total ratings
40.74%
Success rate
12.52%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRNA Verona Pharma | Maintains: Overweight | $76 → $160 | $93.82 | +70.54% | 3 | Jun 23, 2025 | |
| TVRD Tvardi Therapeutics | Initiates: Overweight | $78 | $24.35 | +220.33% | 1 | Jun 12, 2025 | |
| PRTA Prothena Corporation | Maintains: Overweight | $110 → $81 | $6.08 | +1,232.24% | 3 | May 27, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Overweight | $93 → $145 | $83.22 | +74.24% | 2 | Apr 24, 2025 | |
| EWTX Edgewise Therapeutics | Maintains: Overweight | $51 | $13.17 | +287.24% | 4 | Apr 2, 2025 | |
| LXRX Lexicon Pharmaceuticals | Maintains: Overweight | $10 → $6 | $0.82 | +630.91% | 2 | Mar 7, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Overweight | $48 | $4.78 | +904.18% | 1 | Feb 28, 2025 | |
| DRUG Bright Minds Biosciences | Initiates: Overweight | $93 | $23.27 | +299.66% | 1 | Jan 23, 2025 | |
| UPB Upstream Bio | Initiates: Overweight | $75 | $10.93 | +586.18% | 1 | Nov 5, 2024 | |
| NKTR Nektar Therapeutics | Initiates: Overweight | $105 | $25.76 | +307.61% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $52 → $26 | $9.14 | +184.46% | 2 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $37 | $18.57 | +99.25% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $1.05 | +2,376.19% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $0.70 | +3,900.00% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $29.96 | +223.77% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $270 | $43.00 | +527.91% | 3 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $19.80 | +283.84% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $3.50 | +614.29% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $11.35 | +164.32% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $3.61 | +232.87% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $6.80 | +1,223.53% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 | $12.03 | +1,396.26% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $1.25 | +1,100.00% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $336 | $300.28 | +11.90% | 3 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $2.21 | +623.98% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $22.41 | +256.98% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $21.08 | +341.18% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $65 | $16.49 | +294.18% | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $16.10 | +254.04% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $7.87 | +751.33% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $55.69 | -37.15% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $7.50 | +1,060.00% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $7.21 | +2,327.18% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $33.16 | +117.13% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $63 → $27 | $1.25 | +2,060.00% | 1 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $54 → $19 | $9.86 | +92.70% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $2.34 | +2,036.75% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $0.61 | +6,461.68% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.49 | +3,540.04% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $15.71 | +2,573.46% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $13.33 | +477.64% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $51.07 | +50.77% | 1 | Jul 31, 2020 |
Verona Pharma
Jun 23, 2025
Maintains: Overweight
Price Target: $76 → $160
Current: $93.82
Upside: +70.54%
Tvardi Therapeutics
Jun 12, 2025
Initiates: Overweight
Price Target: $78
Current: $24.35
Upside: +220.33%
Prothena Corporation
May 27, 2025
Maintains: Overweight
Price Target: $110 → $81
Current: $6.08
Upside: +1,232.24%
Soleno Therapeutics
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $83.22
Upside: +74.24%
Edgewise Therapeutics
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $13.17
Upside: +287.24%
Lexicon Pharmaceuticals
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $0.82
Upside: +630.91%
Avalo Therapeutics
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $4.78
Upside: +904.18%
Bright Minds Biosciences
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $23.27
Upside: +299.66%
Upstream Bio
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $10.93
Upside: +586.18%
Nektar Therapeutics
Nov 4, 2024
Initiates: Overweight
Price Target: $105
Current: $25.76
Upside: +307.61%
Oct 30, 2024
Reiterates: Overweight
Price Target: $52 → $26
Current: $9.14
Upside: +184.46%
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $18.57
Upside: +99.25%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $1.05
Upside: +2,376.19%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $0.70
Upside: +3,900.00%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $29.96
Upside: +223.77%
Jul 1, 2024
Maintains: Overweight
Price Target: $270
Current: $43.00
Upside: +527.91%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $19.80
Upside: +283.84%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $3.50
Upside: +614.29%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $11.35
Upside: +164.32%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $3.61
Upside: +232.87%
Apr 4, 2024
Initiates: Overweight
Price Target: $90
Current: $6.80
Upside: +1,223.53%
Mar 27, 2024
Maintains: Overweight
Price Target: $180
Current: $12.03
Upside: +1,396.26%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $1.25
Upside: +1,100.00%
Mar 14, 2024
Reiterates: Overweight
Price Target: $336
Current: $300.28
Upside: +11.90%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $2.21
Upside: +623.98%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $22.41
Upside: +256.98%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $21.08
Upside: +341.18%
Oct 25, 2023
Initiates: Overweight
Price Target: $65
Current: $16.49
Upside: +294.18%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $16.10
Upside: +254.04%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $7.87
Upside: +751.33%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $55.69
Upside: -37.15%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $7.50
Upside: +1,060.00%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $7.21
Upside: +2,327.18%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $33.16
Upside: +117.13%
May 18, 2022
Maintains: Overweight
Price Target: $63 → $27
Current: $1.25
Upside: +2,060.00%
May 18, 2022
Maintains: Overweight
Price Target: $54 → $19
Current: $9.86
Upside: +92.70%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $2.34
Upside: +2,036.75%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $0.61
Upside: +6,461.68%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.49
Upside: +3,540.04%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $15.71
Upside: +2,573.46%
Aug 26, 2020
Initiates: Overweight
Price Target: $77
Current: $13.33
Upside: +477.64%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $51.07
Upside: +50.77%